SenesTech (NASDAQ: SNES), the rodent fertility control experts and inventors of ContraPest(R), the only EPA-registered contraceptive for male and female rats, is reporting that the product is being used at new vertical, waste-water treatment facilities in both Washington and California. According to the announcement, waste-water management presents a “unique challenge” when controlling rat infestations because poisons cannot be introduced into the water supply and ground-based stations may not be appropriate. The company noted that a local pest-control company is using both bait stations and Elevate(TM) at the Washington facility while above-ground Elevate stations are being used at the California facility. “Municipalities and government entities comprise a broad and diverse customer base,” said SenesTech president and CEO Joel Fruendt in the press release. “We are continuously working with these customers, and the pest-management professionals who service them, to understand their specific needs and to guide them as to how best to add ContraPest to their integrated pest management system. Waste-water treatment deployment has very specific challenges, and we are able to develop and share deployment protocols utilized by other, similar customers.”
To view the full press release, visit https://ibn.fm/vZrDj
About SenesTech Inc.
SenesTech are experts at rat-fertility control. The company is passionate about creating a healthy environment by better controlling rat pest populations. SenesTech keeps an inescapable truth in mind: two rats and their descendants can be responsible for the birth of up to 15,000 pups after a year. SenesTech invented ContraPest, the only U.S. EPA-registered contraceptive for male and female rats. ContraPest fits seamlessly into all integrated pest-management programs, greatly improving the overall goal of effective rat management. The company strives for clean cities, efficient businesses and happy households by offering a product that was designed to be effective and sustainable without killing rats. SenesTech is committed to improving the health of the world by humanely managing animal populations through fertility control. For more information about the company, please visit www.SenesTech.com.
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]
InvestorWire is powered by IBN